陶秘華博士
研究員
- 02-2789-9151 (L) (Lab) (Room No: N229)
- 02-2652-3078 (O) (Office)
- 02-2782-9142 (Fax)
-
Specialty:
mRNA neoantigen cancer vaccine
COVID-19 mRNA vaccine
Adeno-associated virus (AAV)-based gene therapy
Cancer immunotherapy
Hepatitis B immunotherapy
Translational medicine
Education and Positions:
Ph.D. Columbia University (Microbiology and Immunology).
Postdoctoral Fellow. Stanford University (Oncology)
Dr. Tao, Mi-Hua 's
Publications
期刊 88 專書 0
- Hsu FF, Liang KH, Kumari M, Chen WY, Lin HT, Cheng CM, Tao MH, Wu HC An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization.. International Journal of Pharmaceutics 627, 122256 (2022) [JCR] [WOS]
- Sung PS, Yang SP, Peng YC, Sun CP, Tao MH, Hsieh SL CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.. Journal of Biomedical Science 29(1), 52 (2022) [JCR] [WOS]
- Liang Kang-Hao, Chiang Pao-Yin, Ko Shih-Han, Chou Yu-Chi, Lu Ruei-Min, Lin Hsiu-Ting, Chen Wan-Yu, Lin Yi-Ling, Tao Mi-Hua, Jan Jia-Tsrong, Wu Han-Chung Antibody cocktail effective against variants of SARS-CoV-2. Journal of Biomedical Science 28(1), 80 (2021-11-23) [JCR] [WOS]
- Liang YJ, Teng W, Chen CL, Sun CP, Teng RD, Huang YH, Liang KH, Chen YW, Lin CC, Su CW, Tao MH, Wu JC Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.. HEPATOLOGY (2021) [JCR] [WOS]
- Lien CE, Lin YJ, Chen C, Lian WC, Kuo TY, Campbell JD, Traquina P, Lin MY, Liu LT, Chuang YS, Ko HY, Liao CC, Chen YH, Jan JT, Ma HH, Sun CP, Lin YS, Wu PY, Wang YC, Tao MH*, Lin YL* CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.. Scientific Reports 11(1), 8761 (2021) [JCR] [WOS]
- Su SH, Yang TJ, Yu PY, Kang-Hao Liang KH, Chen WY, Yang CW, Wang MJ, Lin HT, Lu RM, Tso HC, Chung MJ, Hsieh TY, Chang YL, Lin SC, Fang-Yu Hsu FY, Ke FY, Wu YH, Hwang YC, Liang JJ, Liao CC, Sun CP, Wu PY, Lin YL*, Tao MH*, Liao JC*, Hsu STD*, Wu HC* Potent neutralizing antibody cocktail for prevention and treatment of COVID-19. PLOS PATHOGENS (2021) [JCR] [WOS]
- Huang HC, Liao CC, Wang SH, Lee IJ, Lee TA, Hsu JM, Kuo CT, Wang J, Hsieh WC, Chang SJ, Chen SY, Tao MH, Lin YL, Lai YJ, Li CW Hyperglycosylated spike of SARS-CoV-2 gamma variant induces breast cancer metastasis.. American Journal of Cancer Research 11(10), 4994-5005 (2021) [JCR] [WOS]
- Wu CR, Kim HJ, Sun CP, Chung CY, Lin YY, Tao MH, Kim JH, Chen DS, Chen PJ Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants.. Hepatology (Baltimore, Md.) Dec. 27, 00 (2021) [JCR] [WOS]
- Huang PH, Tsai HH, Liao BH, Lin YL, Jan JT, Tao MH, Chou YC, Hu CJ, Chen HW. Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain.. HUMAN VACCINES & IMMUNOTHERAPEUTICS 17(3), 654-655 (2021) [JCR] [WOS]
- Sun CP, Jan JT, Wang IH, Ma HH, Ko HY, Wu PY, Kuo TJ, Liao HN, Lan YH, Sie ZL, Chen YH, Ko YA, Liao CC, Chen LY, Lee IJ, Tsung SI, Lai YJ, Chiang MT, Liang JJ, Liu WC, Wang JR, Yuan JP, Lin YS, Tsai YC, Hsieh SL, Li CW, Wu HC, Ko TM, Lin YL, Tao MH Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19.. PLoS pathogens 17(8), e1009758 (2021) [JCR] [WOS]